Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03334708 · ClinicalTrials.gov registry record
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
A clinical trial of Pancreatic Cancer and Pancreatic Cyst, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 700
- Enrollment target
- 13
- Study locations
NCT03334708 is a study of Pancreatic Cancer and Pancreatic Cyst that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 700 participants, above the 391-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (79% higher). The trial reports 13 study locations across 3 states.
The verdict
NCT03334708, a study of Pancreatic Cancer and Pancreatic Cyst, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood Draw
- DIAGNOSTIC_TEST Tumor Tissue Collection
- DIAGNOSTIC_TEST Cyst Fluid
Study Locations (13)
New York
- Cold Springs Harbor Laboratory (Specimen Analysis) - Cold Spring Harbor
- Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All protocol activities) - Harrison
- New York University - New York
- Memorial Sloan - Kettering Cancer Center - New York
- Memorial Sloan Kettering Basking Ridge (All protocol activities) - New York
- Weill Cornell Medical Center - New York
- Memorial Sloan Kettering Nassau (All protocol activities) - Rockville Centre
Other
- Sha'are Zedek Medical Center - Jerusalem
- Weizmann Institute of Science - Rehovot
- Sheba Medical Center - Tel Litwinsky
New Jersey
- Memorial Sloan Kettering Monmouth (All protocol activities) - Middletown
- Memorial Sloan Kettering Bergen (All protocol activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2017-10-30 |
| Est. Completion | 2026-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03334708
The ClinicalTrials.gov registry entry for NCT03334708 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 391-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (79% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which Blood Draw is the first listed.
NCT03334708 reports 13 study locations spanning 3 distinct geographic areas - top geographies include New York, Other, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03334708 about?
NCT03334708 is a clinical study titled "A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma". The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.
What is the current status of trial NCT03334708?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2017-10-30. Estimated completion is 2026-10-30.
What conditions does trial NCT03334708 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Pancreatic Cyst, Pancreatitis, Pancreatic Diseases.
What interventions are being tested in trial NCT03334708?
The interventions under investigation include: Blood Draw (DIAGNOSTIC_TEST), Tumor Tissue Collection (DIAGNOSTIC_TEST), Cyst Fluid (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03334708?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03334708 being conducted?
This trial has 13 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.